Format
Sort by

Send to

Choose Destination

Search results

Items: 17

1.

A Tool for Assessing a Community's Capacity for Substance Abuse Care.

Green B, Lyerla R, Stroup DF, Azofeifa A, High PM.

Prev Chronic Dis. 2016 Sep 22;13:E133. doi: 10.5888/pcd13.160190.

2.

National Estimates of Marijuana Use and Related Indicators - National Survey on Drug Use and Health, United States, 2002-2014.

Azofeifa A, Mattson ME, Schauer G, McAfee T, Grant A, Lyerla R.

MMWR Surveill Summ. 2016 Sep 2;65(11):1-28. doi: 10.15585/mmwr.ss6511a1.

PMID:
27584586
3.

Driving Under the Influence of Alcohol, Marijuana, and Alcohol and Marijuana Combined Among Persons Aged 16-25 Years - United States, 2002-2014.

Azofeifa A, Mattson ME, Lyerla R.

MMWR Morb Mortal Wkly Rep. 2015 Dec 11;64(48):1325-9. doi: 10.15585/mmwr.mm6448a1.

4.

Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa.

Heaton LM, Bouey PD, Fu J, Stover J, Fowler TB, Lyerla R, Mahy M.

Sex Transm Infect. 2015 Dec;91(8):615-20. doi: 10.1136/sextrans-2014-051991.

PMID:
26056389
5.

The use of epidemiological data to inform the PEPFAR response.

Lyerla R, Murrill CS, Ghys PD, Calleja-Garcia JM, DeCock KM.

J Acquir Immune Defic Syndr. 2012 Aug 15;60 Suppl 3:S57-62. doi: 10.1097/QAI.0b013e31825d279a. Review.

PMID:
22797741
6.

History of statistics in public health at CDC, 1960-2010: the rise of statistical evidence.

Stroup DF, Lyerla R; Centers for Disease Control and Prevention (CDC)..

MMWR Suppl. 2011 Oct 7;60(4):35-41. No abstract available.

PMID:
21976164
7.

Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR).

Padian NS, Holmes CB, McCoy SI, Lyerla R, Bouey PD, Goosby EP.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):199-203. doi: 10.1097/QAI.0b013e31820bb448. No abstract available.

PMID:
21239991
8.

Counting hard-to-count populations: the network scale-up method for public health.

Bernard HR, Hallett T, Iovita A, Johnsen EC, Lyerla R, McCarty C, Mahy M, Salganik MJ, Saliuk T, Scutelniciuc O, Shelley GA, Sirinirund P, Weir S, Stroup DF.

Sex Transm Infect. 2010 Dec;86 Suppl 2:ii11-5. doi: 10.1136/sti.2010.044446.

9.

Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007.

Komatsu R, Korenromp EL, Low-Beer D, Watt C, Dye C, Steketee RW, Nahlen BL, Lyerla R, Garcia-Calleja JM, Cutler J, Schwartländer B.

BMC Infect Dis. 2010 Apr 30;10:109. doi: 10.1186/1471-2334-10-109.

10.

Estimating levels of HIV testing, HIV prevention coverage, HIV knowledge, and condom use among men who have sex with men (MSM) in low-income and middle-income countries.

Adam PC, de Wit JB, Toskin I, Mathers BM, Nashkhoev M, Zablotska I, Lyerla R, Rugg D.

J Acquir Immune Defic Syndr. 2009 Dec;52 Suppl 2:S143-51. doi: 10.1097/QAI.0b013e3181baf111.

PMID:
19901627
11.

Estimating the level of HIV prevention coverage, knowledge and protective behavior among injecting drug users: what does the 2008 UNGASS reporting round tell us?

Mathers BM, Degenhardt L, Adam P, Toskin I, Nashkhoev M, Lyerla R, Rugg D.

J Acquir Immune Defic Syndr. 2009 Dec;52 Suppl 2:S132-42. doi: 10.1097/QAI.0b013e3181baf0c5.

PMID:
19901626
12.

The epidemiology of HIV infection among young people aged 15-24 years in southern Africa.

Gouws E, Stanecki KA, Lyerla R, Ghys PD.

AIDS. 2008 Dec;22 Suppl 4:S5-16. doi: 10.1097/01.aids.0000341773.86500.9d.

PMID:
19033755
13.

The Young Men's Survey phase II: hepatitis B immunization and infection among young men who have sex with men.

Weinbaum CM, Lyerla R, Mackellar DA, Valleroy LA, Secura GM, Behel SK, Bingham T, Celentano DD, Koblin BA, Lalota M, Shehan DA, Thiede H, Torian LV; Young Men's Survey Study Group..

Am J Public Health. 2008 May;98(5):839-45. doi: 10.2105/AJPH.2006.101915.

14.

Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population.

Hwang LY, Kramer JR, Troisi C, Bull L, Grimes CZ, Lyerla R, Alter MJ.

Hepatology. 2006 Aug;44(2):341-51.

PMID:
16871571
15.

Prevalence and risk factors for hepatitis C virus infection among adolescents in detention.

Bair RM, Baillargeon JG, Kelly PJ, Lerand SJ, Williams JF, Lyerla R, Alter MJ.

Arch Pediatr Adolesc Med. 2005 Nov;159(11):1015-8.

PMID:
16275789
16.

Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention.

Weinbaum C, Lyerla R, Margolis HS; Centers for Disease Control and Prevention..

MMWR Recomm Rep. 2003 Jan 24;52(RR-1):1-36; quiz CE1-4. Erratum in: MMWR Recomm Rep. 2003 Mar 14;52(10):205-14.

17.

Cost-effectiveness of hepatitis B vaccination of prison inmates.

Pisu M, Meltzer MI, Lyerla R.

Vaccine. 2002 Dec 13;21(3-4):312-21.

PMID:
12450707
Items per page

Supplemental Content

Loading ...
Support Center